Publisher: Icon Group International, Inc.
Category: Oncology/Hematology

Oncology/Hematology market research reports by Icon Group International, Inc.

(187 reports matching your criteria)
    • The 2025-2030 World Outlook for Malignant Mesothelioma

      The 2025-2030 World Outlook for Malignant Mesothelioma This study covers the world outlook for malignant mesothelioma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Silent Cancer Therapeutics

      The 2025-2030 World Outlook for Silent Cancer Therapeutics This study covers the world outlook for silent cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Oncology Information System Software

      The 2025-2030 World Outlook for Oncology Information System Software This study covers the world outlook for oncology information system software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Oncology Information Systems

      The 2025-2030 World Outlook for Oncology Information Systems This study covers the world outlook for oncology information systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma

      The 2025-2030 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma This study covers the world outlook for premetrexed and combinations for malignant mesothelioma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More

    • The 2025-2030 World Outlook for Hormone-Drug Breast Cancer Therapeutics

      The 2025-2030 World Outlook for Hormone-Drug Breast Cancer Therapeutics This study covers the world outlook for hormone-drug breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics

      The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics This study covers the world outlook for chemotherapy and other multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More

    • The 2025-2030 World Outlook for Cancer Pain

      The 2025-2030 World Outlook for Cancer Pain This study covers the world outlook for cancer pain across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More

    • The 2025-2030 World Outlook for Cancer Pain Management

      The 2025-2030 World Outlook for Cancer Pain Management This study covers the world outlook for cancer pain management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Cancer Profiling and Pathways

      The 2025-2030 World Outlook for Cancer Profiling and Pathways This study covers the world outlook for cancer profiling and pathways across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Liver Cancer Therapeutics

      The 2025-2030 World Outlook for Liver Cancer Therapeutics This study covers the world outlook for liver cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

    • The 2025-2030 World Outlook for Cancer Supportive Care Products

      The 2025-2030 World Outlook for Cancer Supportive Care Products This study covers the world outlook for cancer supportive care products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Radiology Oncology Surgical Robots Devices

      The 2025-2030 World Outlook for Radiology Oncology Surgical Robots Devices This study covers the world outlook for radiology oncology surgical robots devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2025-2030 World Outlook for Hematological Cancers

      The 2025-2030 World Outlook for Hematological Cancers This study covers the world outlook for hematological cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for External Beam Radiation Oncology Therapies

      The 2025-2030 World Outlook for External Beam Radiation Oncology Therapies This study covers the world outlook for external beam radiation oncology therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics

      The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics This study covers the world outlook for leukemia chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Leukemia Treatments

      The 2025-2030 World Outlook for Leukemia Treatments This study covers the world outlook for leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Head and Neck Cancer Diagnostics

      The 2025-2030 World Outlook for Head and Neck Cancer Diagnostics This study covers the world outlook for head and neck cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Cancer and Tumor Profiling

      The 2025-2030 World Outlook for Cancer and Tumor Profiling This study covers the world outlook for cancer and tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Cancer Liquid Biopsy Products

      The 2025-2030 World Outlook for Cancer Liquid Biopsy Products This study covers the world outlook for cancer liquid biopsy products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Prostate Cancer Diagnostics

      The 2025-2030 World Outlook for Prostate Cancer Diagnostics This study covers the world outlook for prostate cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics

      The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics This study covers the world outlook for prostate cancer nuclear medicine diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More

    • The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics

      The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics This study covers the world outlook for ovarian cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics

      The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics This study covers the world outlook for uterine cancer treatments and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2025-2030 World Outlook for Gynecologic Oncology

      The 2025-2030 World Outlook for Gynecologic Oncology This study covers the world outlook for gynecologic oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

2 3 4 5 6 7 8

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings